Hyeok-Gu Kang

1.2k total citations
24 papers, 934 citations indexed

About

Hyeok-Gu Kang is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Hyeok-Gu Kang has authored 24 papers receiving a total of 934 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Immunology. Recurrent topics in Hyeok-Gu Kang's work include Galectins and Cancer Biology (6 papers), Epigenetics and DNA Methylation (4 papers) and Cancer Cells and Metastasis (4 papers). Hyeok-Gu Kang is often cited by papers focused on Galectins and Cancer Biology (6 papers), Epigenetics and DNA Methylation (4 papers) and Cancer Cells and Metastasis (4 papers). Hyeok-Gu Kang collaborates with scholars based in South Korea, United States and Japan. Hyeok-Gu Kang's co-authors include Kyung‐Hee Chun, Seok-Jun Kim, Yunhee Cho, Hyun‐Woo Lee, Hyun Kyung Kong, Jong Hoon Park, Seok‐Jun Kim, Eun Young Park, Hyeyoung Kim and Je Yeong Ko and has published in prestigious journals such as Cancer Research, Oncogene and Biochemical and Biophysical Research Communications.

In The Last Decade

Hyeok-Gu Kang

24 papers receiving 925 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hyeok-Gu Kang South Korea 17 653 324 224 165 78 24 934
Xiaohui Pan China 16 517 0.8× 306 0.9× 217 1.0× 188 1.1× 52 0.7× 27 853
Wen-Juan Gan China 15 554 0.8× 240 0.7× 258 1.2× 197 1.2× 80 1.0× 31 912
Lei Xi China 13 504 0.8× 311 1.0× 228 1.0× 116 0.7× 72 0.9× 32 870
Eun Ji Lee South Korea 15 552 0.8× 293 0.9× 116 0.5× 85 0.5× 93 1.2× 30 870
He Ren China 16 363 0.6× 281 0.9× 313 1.4× 162 1.0× 64 0.8× 20 726
Ming-Yang Wang Taiwan 12 903 1.4× 536 1.7× 286 1.3× 100 0.6× 79 1.0× 20 1.2k
Monish Ram Makena United States 13 562 0.9× 196 0.6× 295 1.3× 86 0.5× 47 0.6× 27 839
Katherine Drews‐Elger United States 13 514 0.8× 235 0.7× 359 1.6× 159 1.0× 147 1.9× 20 1.0k

Countries citing papers authored by Hyeok-Gu Kang

Since Specialization
Citations

This map shows the geographic impact of Hyeok-Gu Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hyeok-Gu Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hyeok-Gu Kang more than expected).

Fields of papers citing papers by Hyeok-Gu Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hyeok-Gu Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hyeok-Gu Kang. The network helps show where Hyeok-Gu Kang may publish in the future.

Co-authorship network of co-authors of Hyeok-Gu Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Hyeok-Gu Kang. A scholar is included among the top collaborators of Hyeok-Gu Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hyeok-Gu Kang. Hyeok-Gu Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kang, Hyeok-Gu, et al.. (2024). Disrupting Notch signaling related HES1 in myeloid cells reinvigorates antitumor T cell responses. Experimental Hematology and Oncology. 13(1). 122–122. 3 indexed citations
2.
Kim, Yesol, Je Yeong Ko, Sumin Oh, et al.. (2022). Reduced miR-371b-5p expression drives tumor progression via CSDE1/RAC1 regulation in triple-negative breast cancer. Oncogene. 41(22). 3151–3161. 9 indexed citations
3.
Lee, Min Jung, Hae-Young Kim, Kyung‐Hee Chun, et al.. (2021). Extracellular Superoxide Dismutase Prevents Skin Aging by Promoting Collagen Production through the Activation of AMPK and Nrf2/HO-1 Cascades. Journal of Investigative Dermatology. 141(10). 2344–2353.e7. 33 indexed citations
4.
Kim, Seok‐Jun, Hyeok-Gu Kang, Kyungeun Kim, et al.. (2021). Crosstalk between WNT and STAT3 is mediated by galectin-3 in tumor progression. Gastric Cancer. 24(5). 1050–1062. 25 indexed citations
5.
Lee, Dong Hoon, Go Woon Kim, Jung Yoo, et al.. (2021). Histone demethylase KDM4C controls tumorigenesis of glioblastoma by epigenetically regulating p53 and c-Myc. Cell Death and Disease. 12(1). 89–89. 39 indexed citations
6.
Yi, Sang Ah, Dong Hoon Lee, Go Woon Kim, et al.. (2020). HPV-mediated nuclear export of HP1γ drives cervical tumorigenesis by downregulation of p53. Cell Death and Differentiation. 27(9). 2537–2551. 24 indexed citations
7.
Lee, Seul, Hyeok-Gu Kang, Hyun‐Woo Park, et al.. (2020). Synergistic antitumor activity of a DLL4/VEGF bispecific therapeutic antibody in combination with irinotecan in gastric cancer. BMB Reports. 53(10). 533–538. 14 indexed citations
8.
Kim, Yesol, Hyeok-Gu Kang, Jee Won Park, et al.. (2020). Inhibition of Chk1 by miR-320c increases oxaliplatin responsiveness in triple-negative breast cancer. Oncogenesis. 9(10). 91–91. 16 indexed citations
9.
Kim, Yesol, Hyeok-Gu Kang, Jee Won Park, et al.. (2019). miR-374a-5p promotes tumor progression by targeting ARRB1 in triple negative breast cancer. Cancer Letters. 454. 224–233. 60 indexed citations
10.
Kim, Won-Jin, et al.. (2019). Galectin-3 Interacts with C/EBPβ and Upregulates Hyaluronan-Mediated Motility Receptor Expression in Gastric Cancer. Molecular Cancer Research. 18(3). 403–413. 26 indexed citations
11.
Cho, Yunhee, Hyeok-Gu Kang, Seok‐Jun Kim, et al.. (2018). Post-translational modification of OCT4 in breast cancer tumorigenesis. Cell Death and Differentiation. 25(10). 1781–1795. 70 indexed citations
12.
Ann, Eun‐Jung, Mi‐Yeon Kim, Ji‐Hye Yoon, et al.. (2016). Tumor Suppressor HIPK2 Regulates Malignant Growth via Phosphorylation of Notch1. Cancer Research. 76(16). 4728–4740. 16 indexed citations
13.
Kang, Hyeok-Gu, Seok‐Jun Kim, Yunhee Cho, et al.. (2016). Galectin-3 supports stemness in ovarian cancer stem cells by activation of the Notch1 intracellular domain. Oncotarget. 7(42). 68229–68241. 59 indexed citations
14.
Choi, Jieun, Eunjin Koh, Hyun‐Woo Lee, et al.. (2016). Mitochondrial Sirt3 supports cell proliferation by regulating glutamine-dependent oxidation in renal cell carcinoma. Biochemical and Biophysical Research Communications. 474(3). 547–553. 30 indexed citations
15.
Kim, Do Yeon, Eun Young Park, Hyeok-Gu Kang, et al.. (2016). A novel miR-34a target, protein kinase D1, stimulates cancer stemness and drug resistance through GSK3/β-catenin signaling in breast cancer. Oncotarget. 7(12). 14791–14802. 56 indexed citations
16.
Cho, Yunhee, Hyun‐Woo Lee, Hyeok-Gu Kang, et al.. (2015). Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer. Oncotarget. 6(11). 8709–8721. 90 indexed citations
17.
Park, Eun Young, Eun Ji Lee, Hyun-Woo Lee, et al.. (2014). Targeting of miR34a–NOTCH1 Axis Reduced Breast Cancer Stemness and Chemoresistance. Cancer Research. 74(24). 7573–7582. 170 indexed citations
18.
Kim, Seok-Jun, Hyeok-Gu Kang, Hyun‐Woo Lee, et al.. (2014). Galectin-3 Activates PPARγ and Supports White Adipose Tissue Formation and High-Fat Diet-Induced Obesity. Endocrinology. 156(1). 147–156. 80 indexed citations
19.
Kang, Hyeok-Gu & D.H. Bae. (2013). Deformation behavior of a statically recrystallized Mg–Zn–MM alloy sheet. Materials Science and Engineering A. 582. 203–210. 6 indexed citations
20.
Kang, Hyeok-Gu, et al.. (2011). PCN129 Mapping the Cancer-Specific EORTC QLQ-C30 and EORTC QLQ-BR23 to the Generic EQ-5D in Metastatic Breast Cancer Patients. Value in Health. 14(7). A458–A458. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaohui Pan Breakdown of academic impact, for papers by Wen-Juan Gan Breakdown of academic impact, for papers by Lei Xi Breakdown of academic impact, for papers by Eun Ji Lee Breakdown of academic impact, for papers by He Ren Breakdown of academic impact, for papers by Ming-Yang Wang Breakdown of academic impact, for papers by Monish Ram Makena Breakdown of academic impact, for papers by Katherine Drews‐Elger
Rankless by CCL
2026